Condition

Endocrine System Diseases clinical trials and research

• 13Clinical trials
• 1New in 30 days
• 9Countries

Newest Endocrine System Diseases clinical trials

All recruiting trials (13)

• ETHY-001 safety and activity in Thyroid Eye Disease (TED)

  This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.

  Recruiting at 2 sites Phase 1 Ethyreal Bio, Inc. · Orland Park, Illinois and 2 other locations · NCT07885605

• AMX0035 in adults with Type 1 Diabetes

  This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.

  Recruiting Phase 2 University of Washington · Seattle, Washington and 1 other locations · NCT07699380

• Orforglipron for Type 2 Diabetes in Ramadan Fasters

  This study tests whether orforglipron helps people with type 2 diabetes who fast during Ramadan, to see if it improves blood sugar control safely.

  Recruiting at 33 sites Phase 3 Eli Lilly and Company · Agra and 39 other locations · NCT07613307

• Telehealth Music Therapy for adults with autoimmune endocrine disease and depression

  This study tests whether eight weeks of telehealth music therapy can improve quality of life and mood symptoms in adults with autoimmune endocrine diseases and depression.

  Recruiting Appalachian State University · Boone, North Carolina · NCT07413874

• Insulin delivery technology and eating behaviours in people with type 1 diabetes

  This project will test whether automated insulin delivery systems change eating behaviours and make carbohydrate counting easier for people aged 12 and older who have type 1 diabetes in Canada.

  Recruiting McGill University · Montreal, Quebec · NCT07348432

• Higher-dose palopegteriparatide treatment for adults with hypoparathyroidism.

  This 78-week test will see if giving adults with chronic hypoparathyroidism higher doses of palopegteriparatide (above 30 µg/day) is safe and better controls their calcium levels.

  Recruiting at 10 sites Phase 3 Ascendis Pharma A/S · Greeley, Colorado and 9 other locations · NCT07081997

• Evaluating linsitinib for thyroid eye disease

  This study is testing if a new drug called linsitinib can help people with moderate to severe thyroid eye disease who haven't improved with other treatments.

  Recruiting at 2 sites Phase 2/3 Sling Therapeutics, Inc. · Miami, Florida and 1 other locations · NCT06112340

• Using the 'Support' online training and peer program for adults with type 1 diabetes

  This project will test whether adults with type 1 diabetes who get access to the online 'Support' training and peer platform through their diabetes clinic manage their diabetes better than those who use the platform on their own.

  Recruiting at 4 sites McGill University · Montreal, Quebec and 3 other locations · NCT06069583

• Network for studying rare and atypical diabetes

  This study is trying to find and understand rare types of diabetes by testing people and families who haven't been diagnosed yet, using blood tests and genetic screening to learn more about these conditions.

  Recruiting at 13 sites University of South Florida · Aurora, Colorado and 12 other locations · NCT05544266

• Pooling clinical experiences of patients treated with Lutetium-177 in Spain

  This study looks at how well Lutetium-177 works and how safe it is for patients with certain types of tumors in Spain by collecting information from their medical records.

  Recruiting at 11 sites Sociedad Española de Medicina Nuclear e Imagen Molecular · Santiago de Compostela, A Coruña and 19 other locations · NCT04949282

• Registry for patients with unresectable pancreatic cancer treated with OncoSil™

  This study is testing how well the OncoSil™ device works and its safety for people with advanced pancreatic cancer who are also receiving chemotherapy.

  Recruiting at 5 sites OncoSil Medical Limited · Las Palmas de Gran Canaria and 8 other locations · NCT04493632

• Combining testosterone therapy with walking training to improve health after spinal cord injury

  This study is testing if combining testosterone therapy with walking training can help men with spinal cord injuries who have low testosterone and trouble walking improve their health and mobility.

  Recruiting at 2 sites Phase 2 North Florida Foundation for Research and Education · Gainesville, Florida and 1 other locations · NCT04460872

• Real-time continuous glucose monitoring for young adults at risk of DKA

  This project will try a Dexcom G6 real-time continuous glucose monitor to see if it helps 18-25-year-olds with insulin-treated diabetes who have poor blood sugar control or recent hospital admissions for high blood sugar.

  Recruiting Imperial College London · London · NCT04039763

Related topics

Quick answers

How many Endocrine System Diseases clinical trials are recruiting right now?

13, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in United States (7 trials), Spain (2 trials), Canada (2 trials), United Kingdom (2 trials), India (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 2, Phase 2/3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →